bpc 157 breast cancer Body Protecting Compound (BPC-157 ): Overview, Potential Benefits, and Safety BPC-157 – No Proof Required!

On the left is a diagram from a BPC-157 study and on the right from our in-vitro platelet-based tendon healing study (5)

The standard initial loading dose is 1,000 mcg administered intramuscularly (IM) once weekly for 4 weeks

Marketing Claims to Avoid Don't claim BPC-157 heals, cures, or treats anything: not injuries, tissue repair, gut problems, or pain

Beyond Use Date 90 Days from compounding (USP ) Use within this window from the date your vial is compounded

FAQs about AOD-9604 Usage

It consists of 15 amino acids and is part of a class of compounds known as pentadecapeptides , which have shown remarkable regenerative effects in preclinical studies